Orthofix Medical Inc. Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
Orthofix Medical Inc. (OFIX) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of -$360.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-25.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2019-02-25
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-12-31 was -$484.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-09-30 was -$3.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-06-30 was $79.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2016-03-31 was $48.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2016 was -$360.00K, a 278.22% decline from fiscal 2015.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2015 was $202.00K, a 34.20% decline from fiscal 2014.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2014 was $307.00K.
- Orthofix Medical Inc. other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2013 was -$443.00K.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$487.00K derived: sum of 2 quarters · filed 2019-02-25 | -$408.00K derived: sum of 3 quarters · filed 2019-02-25 | -$360.00K 10-K · filed 2019-02-25 |
| 2016-09-30 | -$3.00K 10-Q · filed 2017-10-30 | $76.00K derived: sum of 2 quarters · filed 2017-10-30 | $124.00K 10-Q · filed 2017-10-30 | |
| 2016-06-30 | $79.00K 10-Q · filed 2017-08-07 | $127.00K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $48.00K 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | $202.00K 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $307.00K 10-K · filed 2017-02-27 | |||
| 2013-12-31 | -$443.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |